Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | F11 | P03951 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24411917 | 0.91 | LPL (0.39) | LPLLIPGROCK1F11 | |
| SCHEMBL13070935 | 0.91 | LPL (0.39) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL202622 | 0.89 | LIPG (0.46) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL30860136 | 0.89 | LIPG (0.46) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL483144 | 0.89 | CASP1 (0.45) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL31222883 | 0.89 | CASP1 (0.45) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL15429671 | 0.88 | LIPG (0.49) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL16639375 | 0.87 | LPL (0.47) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL29502333 | 0.87 | LPL (0.47) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL23767233 | 0.85 | LPL (0.44) | LPLLIPGROCK1F11P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024136111-A1 | FLUORENE-BASED POLYMER, ANION EXCHANGE MEMBRANE, WATER-ELECTROLYSIS DEVICE, AND CARBON DIOXIDE CONVERSION DEVICE | 에스케이이노베이션 주식회사 | 2024-06-27 | — | — | WO | disclosed |
| EP-3699176-A2 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2020-08-26 | — | — | EP | disclosed |
| US-20200123132-A1 | ANTIVIRAL COMPOUNDS | GILEAD PHARMASSET LLC | 2020-04-23 | — | — | US | disclosed |
| EP-3626716-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2020-03-25 | — | — | EP | disclosed |
| US-10559756-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-02-11 | — | — | US | disclosed |
| US-10344019-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2019-07-09 | — | — | US | disclosed |
| US-9981955-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-9981955-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2018-05-29 | — | — | US | disclosed |
| EP-3309157-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-3309157-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20090036623-A1 | PROCESS FOR PRODUCING CONJUGATED POLYMER | HITACHI CHEMICAL CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090036623-A1 | PROCESS FOR PRODUCING CONJUGATED POLYMER | HITACHI CHEMICAL CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20070003783-A1 | Quinoline copolymer and organic electroluminescent device employing same | HITACHI CHEMICAL CO LTD (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20070003783-A1 | Quinoline copolymer and organic electroluminescent device employing same | HITACHI CHEMICAL CO LTD (JP) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10344019-B2 | Antiviral compounds | MAVS, EIF2AK2, ZC3HAV1 | LPL 2383/4885LIPG 1280/4885CA1 4745/4885 |
| US-10559756-B2 | Materials for electronic devices | TEC, EFNA1, BMI1 | LPL 4510/4885LIPG 3626/4885CA1 3105/4885 |
| US-20200123132-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | LPL 2383/4885LIPG 1280/4885CA1 4745/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | LPL 2383/4885LIPG 1280/4885CA1 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.